Interleukin-6 and Interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic–clonic seizures
- 1 October 2000
- journal article
- clinical trial
- Published by Elsevier in Epilepsy Research
- Vol. 41 (3) , 205-211
- https://doi.org/10.1016/s0920-1211(00)00140-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Penetration of interleukin-6 across the murine blood-brain barrierPublished by Elsevier ,2003
- INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in BiologyAnnual Review of Immunology, 1998
- Interleukin-1β levels in serum and cerebrospinal fluid of children with febrile seizuresPediatric Neurology, 1997
- Interleukin‐6 and interleukin‐1 receptor antagonist in acute strokeAnnals of Neurology, 1995
- Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitisEuropean Journal of Neurology, 1994
- Seizure-Induced Changes in Neurotrophin Expression: Implications for EpilepsyExperimental Neurology, 1993
- Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNFα and LIF in the rat brainBiochemical and Biophysical Research Communications, 1991
- Convulsants induce interleukin-1β messenger RNA in rat brainBiochemical and Biophysical Research Communications, 1990
- Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.The Journal of Experimental Medicine, 1989
- Increased Cerebrovascular Permeability to Protein During Systemic Kainic Acid SeizuresEpilepsia, 1984